2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxo-1-pyridinyl]-2-fluoro-N-(1-methylindazol-5-yl)acetamide
C23H17ClFN5O3 — CID 175548410
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxo-1-pyridinyl]-2-fluoro-N-(1-methylindazol-5-yl)acetamide
2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxo-1-pyridinyl]-2-fluoro-N-(1-methylindazol-5-yl)acetamide (PubChem CID 175548410) has the molecular formula C23H17ClFN5O3 and a molecular weight of 465.87 g/mol. Its IUPAC name is 2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxo-1-pyridinyl]-2-fluoro-N-(1-methylindazol-5-yl)acetamide.
Molecular Properties
| Compound Name | 2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxo-1-pyridinyl]-2-fluoro-N-(1-methylindazol-5-yl)acetamide |
|---|---|
| PubChem CID | 175548410 |
| Molecular Formula | C23H17ClFN5O3 |
| Molecular Weight | 465.87 g/mol |
| Exact Mass | 465.10 |
| IUPAC Name | 2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxo-1-pyridinyl]-2-fluoro-N-(1-methylindazol-5-yl)acetamide |
| SMILES | COc1cn(C(F)C(=O)Nc2ccc3c(cnn3C)c2)c(=O)cc1-c1cc(Cl)ccc1C#N |
| InChI | InChI=1S/C23H17ClFN5O3/c1-29-19-6-5-16(7-14(19)11-27-29)28-23(32)22(25)30-12-20(33-2)18(9-21(30)31)17-8-15(24)4-3-13(17)10-26/h3-9,11-12,22H,1-2H3,(H,28,32) |
| InChIKey | OOMZHDJEBOQLJW-UHFFFAOYSA-N |
| XLogP | 4.04 |
| TPSA | 101.94 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 465.87 |
| LogP ≤ 5 | 4.04 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175548410 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.